⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21654555 | 0.78 | — | — | |
| SCHEMBL13169735 | 0.75 | KDM4E (0.46) | — | |
| SCHEMBL15131326 | 0.75 | KDM4E (0.46) | — | |
| SCHEMBL583913 | 0.75 | — | — | |
| SCHEMBL445984 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL10800425 | 0.73 | — | — | |
| SCHEMBL27429709 | 0.73 | — | — | |
| SCHEMBL959382 | 0.72 | — | — | |
| SCHEMBL11439623 | 0.72 | — | — | |
| SCHEMBL960835 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021104120-A1 | POLYETHYLENE GLYCOL CONJUGATE MEDICAMENT, PREPARATION METHOD THERFOR AND USE THEREOF | 重庆阿普格雷生物科技有限公司 | 2021-06-03 | — | — | WO | disclosed |
| EP-3263598-B1 | CAMPTOTHECIN-BINDING MOIETY CONJUGATES | IMMUNOMEDICS INC (US) | 2020-09-09 | — | — | EP | disclosed |
| EP-3263598-A1 | CAMPTOTHECIN-BINDING MOIETY CONJUGATES | Immunomedics Inc. (US) | 2018-01-03 | — | — | EP | disclosed |
| CN-103261300-B | Comprise hydrazides, hydrazone and polyamines based on natural rubber and the compositions of white carbon black | 米其林集团总公司 | 2016-08-10 | — | — | CN | disclosed |
| US-8877901-B2 | Camptothecin-binding moiety conjugates | IMMUNOMEDICS, INC. (US) | 2014-11-04 | — | — | US | disclosed |
| EP-2248833-B1 | MODIFIED DIENE RUBBER, METHOD FOR PRODUCING THE SAME, RUBBER COMPOSITION USING THE SAME, AND TIRE | BRIDGESTONE CORP (JP) | 2014-03-26 | — | — | EP | disclosed |
| CN-102099380-B | Modified diene rubber, method for producing same, rubber composition using same, and tire | BRIDGESTONE CORP | 2014-03-12 | — | — | CN | disclosed |
| US-20130289165-A1 | COMPOSITION BASED ON NATURAL RUBBER AND CARBON BLACK COMPRISING A HYDRAZIDE, A HYDRAZONE AND A POLYAMINE | MICHELIN RECHERCHE ET TECHNIQUE S.A. (CH) | 2013-10-31 | — | — | US | disclosed |
| EP-2655495-A1 | COMPOSITION BASED ON NATURAL RUBBER AND CARBON BLACK COMPRISING A HYDRAZIDE, A HYDRAZONE AND A POLYAMINE | Compagnie Générale des Etablissements Michelin (FR) | 2013-10-30 | — | — | EP | disclosed |
| CN-103261300-A | Composition based on natural rubber and carbon black comprising hydrazide, hydrazone and polyamine | MICHELIN RECH TECH | 2013-08-21 | — | — | CN | disclosed |
| US-6897231-B2 | Indazole derivatives as JNK inhibitors and compositions and methods related thereto | SIGNAL PHARMACEUTICALS, INC. (US) | 2005-05-24 | — | — | US | disclosed |
| US-20050107457-A1 | Indazole derivatives as JNK inhibitors and compositions and methods related thereto | SINGNAL PHARMACEUTICALS, INC. | 2005-05-19 | — | — | US | disclosed |
| US-20050009876-A1 | Indazole compounds, compositions thereof and methods of treatment therewith | SIGNAL PHARMACEUTICALS, LLC | 2005-01-13 | — | — | US | disclosed |
| WO-2004094388-A2 | INDAZOLE DERIVATIVES AS JNK INHIBITORS | SIGNAL PHARMACEUTICALS, LLC (US) | 2004-11-04 | — | — | WO | disclosed |
| US-20040127536-A1 | Methods for treating an inflammatory condition or inhibiting JNK | SIGNAL PHARMACEUTICALS, LLC | 2004-07-01 | — | — | US | disclosed |
| US-20040077877-A1 | Indazole derivatives as JNK inhibitors and compositions and methods related thereto | SIGNAL PHARMACEUTICALS, INC. | 2004-04-22 | — | — | US | disclosed |
| EP-1313711-A2 | INDAZOLE DERIVATIVES AS JNK INHIBITORS | SIGNAL PHARMACEUTICALS, INC. (US) | 2003-05-28 | — | — | EP | disclosed |
| WO-2002010137-A9 | INDAZOLE DERIVATIVES AS JNK INHIBITORS | SIGNAL PHARM INC (US) | 2003-02-06 | — | — | WO | disclosed |
| US-20020103229-A1 | Indazole derivatives as JNK inhibitors and compositions and methods related thereto | SIGNAL PHARMACEUTICALS, LLC | 2002-08-01 | — | — | US | disclosed |
| WO-2002010137-A2 | INDAZOLE DERIVATIVES AS JNK INHIBITORS | SIGNAL PHARMACEUTICALS, INC. (US) | 2002-02-07 | — | — | WO | disclosed |